脑出血后是否应恢复抗凝治疗？
Should anticoagulation be resumed after intracerebral hemorrhage?
机构信息
Department of Emergency Medicine, Massachusetts General Hospital, Zero Emerson Place, Suite 3B, Boston, MA 02114, USA.
出版信息
Cleve Clin J Med. 2010 Nov;77(11):791-9. doi: 10.3949/ccjm.77a.10018.
Abstract
Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation-associated ICH.
摘要
脑出血（ICH）是口服抗凝药物治疗（如华法林）最令人恐惧和致命的并发症。在这种情况下，临床医生会想知道他们的患者是否应该恢复抗凝治疗。作者回顾了抗凝相关性 ICH 期间和之后的抗凝管理。
相似文献
1
Should anticoagulation be resumed after intracerebral hemorrhage?脑出血后是否应恢复抗凝治疗？
Cleve Clin J Med. 2010 Nov;77(11):791-9. doi: 10.3949/ccjm.77a.10018.
2
Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.口服抗凝相关脑出血非工作时间血压与抗凝逆转管理。
Cerebrovasc Dis. 2020;49(2):177-184. doi: 10.1159/000507316. Epub 2020 Apr 22.
3
Oral anticoagulant-associated intracerebral hemorrhage.口服抗凝剂相关的颅内出血。
J Neurol. 2012 Feb;259(2):212-24. doi: 10.1007/s00415-011-6153-3. Epub 2011 Jul 5.
4
Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.新型口服抗凝药相关脑出血的治疗：神经科医生的观点
Clin Lab Med. 2014 Sep;34(3):587-94. doi: 10.1016/j.cll.2014.06.007. Epub 2014 Jul 29.
5
Oral-anticoagulant-related intracerebral hemorrhage.口服抗凝剂相关的脑出血。
Thromb Res. 2002 Oct 1;108(1):31-6. doi: 10.1016/s0049-3848(02)00398-5.
6
Anticoagulation Resumption After Intracerebral Hemorrhage.脑出血后抗凝的恢复。
Curr Atheroscler Rep. 2018 May 21;20(7):32. doi: 10.1007/s11883-018-0733-y.
7
Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.接受口服抗凝治疗患者的脑出血
J Intensive Care Med. 2015 Feb;30(2):63-78. doi: 10.1177/0885066613488732. Epub 2013 May 20.
8
Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.服用非维生素K拮抗剂与维生素K拮抗剂口服抗凝剂的患者发生脑出血与院内死亡率的关联
JAMA. 2018 Feb 6;319(5):463-473. doi: 10.1001/jama.2017.21917.
9
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.脑白质疏松症与缺血性卒中后华法林相关的出血有关。
Neurology. 2002 Jul 23;59(2):193-7. doi: 10.1212/wnl.59.2.193.
10
Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.华法林治疗脑出血时，较高的基线国际标准化比值与较高的死亡率相关。
Eur J Neurol. 2014 Apr;21(4):616-22. doi: 10.1111/ene.12352. Epub 2014 Jan 21.
引用本文的文献
1
The risks, timing and safety of anticoagulation therapy following intracranial surgery: a systematic review and meta-analysis.颅内手术后抗凝治疗的风险、时机及安全性：一项系统评价与荟萃分析
Neurosurg Rev. 2025 May 29;48(1):453. doi: 10.1007/s10143-025-03580-4.
2
Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-1: Diagnostic and Therapeutic Challenges).心肌心尖球囊综合征：实用挑战和特殊情况的国际专家共识报告（第一部分：诊断和治疗挑战）
Balkan Med J. 2024 Oct 31;41(6):421-441. doi: 10.4274/balkanmedj.galenos.2024.2024-9-98. Epub 2024 Oct 17.
3
Cases from a Community Hospital…JCHIMP Series #1: 55-Year-Old Male with Acute PE Who Developed Persistent Epistaxis.一家社区医院的病例……《日本临床血液学与输血医学杂志》系列#1：一名55岁男性急性肺栓塞患者并发持续性鼻出血。
J Community Hosp Intern Med Perspect. 2022 May 2;12(3):21-27. doi: 10.55729/2000-9666.1049. eCollection 2022.
4
Anticoagulation and bleeding in the cancer patient.癌症患者的抗凝和出血问题。
Support Care Cancer. 2022 Oct;30(10):8547-8557. doi: 10.1007/s00520-022-07136-w. Epub 2022 May 17.
5
Predicting Early Seizures After Intracerebral Hemorrhage with Machine Learning.利用机器学习预测脑出血后的早期发作。
Neurocrit Care. 2022 Aug;37(Suppl 2):322-327. doi: 10.1007/s12028-022-01470-x. Epub 2022 Mar 14.
6
Application of magnetically actuated self-clearing catheter for rapid in situ blood clot clearance in hemorrhagic stroke treatment.磁驱动自清除导管在出血性脑卒中治疗中快速原位血栓清除的应用。
Nat Commun. 2022 Jan 26;13(1):520. doi: 10.1038/s41467-022-28101-5.
7
Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding.新冠肺炎合并胃肠道出血患者复发性出血和血栓栓塞性疾病的观察性风险
Endosc Int Open. 2021 Aug 23;9(9):E1435-E1444. doi: 10.1055/a-1497-1801. eCollection 2021 Sep.
8
The importance of adherence and persistence in the elderly atrial fibrillation patient.老年房颤患者坚持治疗和持续用药的重要性。
Eur Heart J Suppl. 2020 Sep 15;22(Suppl I):I38-I42. doi: 10.1093/eurheartj/suaa103. eCollection 2020 Sep.
9
Management of thrombocytopenia in a patient with a mechanical mitral valve undergoing autologous hematopoietic stem cell transplantation: case report and review of literature.机械二尖瓣置换术后患者自体造血干细胞移植时血小板减少症的管理：病例报告及文献综述
Am J Blood Res. 2020 Feb 15;10(1):11-14. eCollection 2020.
10
Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report.颅内出血后静脉血栓栓塞的治疗：一例报告
Cureus. 2020 Jan 22;12(1):e6746. doi: 10.7759/cureus.6746.
本文引用的文献
1
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.抗血栓药物治疗缺血性卒中和短暂性脑缺血发作以预防复发性主要血管事件。
Lancet Neurol. 2010 Mar;9(3):273-84. doi: 10.1016/S1474-4422(10)70038-7.
2
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.患者特征是否会影响非瓣膜性心房颤动患者预防卒中的目标抗凝强度？：ATRIA研究。
Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):297-304. doi: 10.1161/CIRCOUTCOMES.108.830232. Epub 2009 Jun 9.
3
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.达比加群酯与华法林治疗急性静脉血栓栓塞症的比较。
N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598.
4
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.重组活化因子 VII 治疗自发性脑出血的血栓栓塞事件：来自急性出血性卒中因子 VII （FAST）试验的结果。
Stroke. 2010 Jan;41(1):48-53. doi: 10.1161/STROKEAHA.109.561712. Epub 2009 Dec 3.
5
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors.原发性脑出血的点征评分可识别出院内死亡率最高和幸存者预后不良的高危患者。
Stroke. 2010 Jan;41(1):54-60. doi: 10.1161/STROKEAHA.109.565382. Epub 2009 Nov 12.
6
Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.抗血小板药物在脑出血急性期血肿扩大中的作用。
Neurocrit Care. 2010 Feb;12(1):24-9. doi: 10.1007/s12028-009-9290-0.
7
The net clinical benefit of warfarin anticoagulation in atrial fibrillation.华法林抗凝治疗心房颤动的净临床获益。
Ann Intern Med. 2009 Sep 1;151(5):297-305. doi: 10.7326/0003-4819-151-5-200909010-00003.
8
Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score.原发性脑出血计算机断层血管造影斑点征的系统特征分析可识别血肿扩大风险最高的患者：斑点征评分
Stroke. 2009 Sep;40(9):2994-3000. doi: 10.1161/STROKEAHA.109.554667. Epub 2009 Jul 2.
9
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.血小板活性降低与脑出血后早期血栓形成及3个月时更差的预后相关。
Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14.
10
Density and shape as CT predictors of intracerebral hemorrhage growth.作为脑出血进展的CT预测指标的密度和形状
Stroke. 2009 Apr;40(4):1325-31. doi: 10.1161/STROKEAHA.108.536888. Epub 2009 Mar 12.
Zotero 插件